Perjeta, also known as pertuzumab, signifies a crucial advancement in treating HER2-positive mammary cancer. It works by blocking a distinct pathway that helps cancer cells grow . Unlike some alternative HER2-targeted therapies, pertuzumab avoids directly block the HER2 receptor itself, but inste